BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38477985)

  • 1. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
    Chung DC; Gray DM; Singh H; Issaka RB; Raymond VM; Eagle C; Hu S; Chudova DI; Talasaz A; Greenson JK; Sinicrope FA; Gupta S; Grady WM
    N Engl J Med; 2024 Mar; 390(11):973-983. PubMed ID: 38477985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening.
    Imperiale TF; Porter K; Zella J; Gagrat ZD; Olson MC; Statz S; Garces J; Lavin PT; Aguilar H; Brinberg D; Berkelhammer C; Kisiel JB; Limburg PJ;
    N Engl J Med; 2024 Mar; 390(11):984-993. PubMed ID: 38477986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multitarget stool DNA testing for colorectal-cancer screening.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Levin TR; Lavin P; Lidgard GP; Ahlquist DA; Berger BM
    N Engl J Med; 2014 Apr; 370(14):1287-97. PubMed ID: 24645800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study.
    Imperiale TF; Kisiel JB; Itzkowitz SH; Scheu B; Duimstra EK; Statz S; Berger BM; Limburg PJ
    Cancer Prev Res (Phila); 2021 Apr; 14(4):489-496. PubMed ID: 33436397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.
    Grobbee EJ; Wisse PHA; Schreuders EH; van Roon A; van Dam L; Zauber AG; Lansdorp-Vogelaar I; Bramer W; Berhane S; Deeks JJ; Steyerberg EW; van Leerdam ME; Spaander MC; Kuipers EJ
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD009276. PubMed ID: 35665911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
    Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
    Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
    Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
    World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study.
    Imperiale TF; Lavin PT; Marti TN; Jakubowski D; Itzkowitz SH; May FP; Limburg PJ; Sweetser S; Daghestani A; Berger BM
    Cancer Prev Res (Phila); 2023 Feb; 16(2):89-97. PubMed ID: 36205504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
    Sharma T
    Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
    Prince M; Lester L; Chiniwala R; Berger B
    World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 15. A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions.
    Li Y; Li B; Jiang R; Liao L; Zheng C; Yuan J; Zeng L; Hu K; Zhang Y; Mei W; Hong Z; Xiao B; Kong L; Han K; Tang J; Jiang W; Pan Z; Zhang S; Ding P
    Cancer Med; 2023 Nov; 12(21):20626-20638. PubMed ID: 37881109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.
    Malagón M; Ramió-Pujol S; Serrano M; Serra-Pagès M; Amoedo J; Oliver L; Bahí A; Mas-de-Xaxars T; Torrealba L; Gilabert P; Miquel-Cusachs JO; García-Nimo L; Saló J; Guardiola J; Piñol V; Cubiella J; Castells A; Aldeguer X; Garcia-Gil J
    Aliment Pharmacol Ther; 2019 Jun; 49(11):1410-1420. PubMed ID: 31025420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial.
    Singal AG; Gupta S; Skinner CS; Ahn C; Santini NO; Agrawal D; Mayorga CA; Murphy C; Tiro JA; McCallister K; Sanders JM; Bishop WP; Loewen AC; Halm EA
    JAMA; 2017 Sep; 318(9):806-815. PubMed ID: 28873161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA.
    Ebner DW; Eckmann JD; Burger KN; Mahoney DW; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Finney Rutten LJ; Gurudu SR; Kisiel JB
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00375. PubMed ID: 34140458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
    Yang H; Ge Z; Dai J; Li X; Gao Y
    Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
    de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
    Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.